Table 2 Summary of pediatric patients’ baseline of included studies
Author | Treatment | Age, years | Sex | Stone location, n (units) | Side | Stone size, mm | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pelvis | Caliceal | Pelvis + caliceal | Staghorn stone | |||||||||
(Mean ± SD) | Male | Female | Partial | Complete | Unilateral | Bilateral | (Mean ± SD) | |||||
Zeng et al [15] | SWL | 1.96 ± 0.55 | 17 | 5 | 5(5) | 0(0) | 2(2) | 15(15) | 0(0) | 22 | 0 | 21.7 ± 1.7 |
PCNL | 1.92 ± 0.8 | 15 | 9 | 6(7) | 0(0) | 3(4) | 12(12) | 3(3) | 24 | 1 | 21.4 ± 3.5 | |
Wadhwa et al [16] | SWL | 3~12 | 11 | 3 | 8(9) | 0(0) | 0(0) | 0(0) | 0(0) | NA | 220.4a | |
PCNL | 5.9 | NA(4) | 0(0) | NA(4) | 1(1) | 0(0) | 1393.4a | |||||
Kumar et al [17] | SWL | 10.7 ± 1.3 | 52 | 54 | NA | 106 | 0 | 12.9 ± 1.3 | ||||
PCNL | 10.3 ± 1.2 | 51 | 55 | 106 | 0 | 12.7 ± 1.2 | ||||||
Hatipoglu et al [18] | SWL | 5.91 ± 4.03 | 61 | 47 | 50 | 58 | 0(0) | 0(0) | 0(0) | 108 | 0 | 11.32 ± 2.84 |
PCNL | 8.43 ± 4.84 | 15 | 22 | 10 | 27 | 0(0) | 0(0) | 0(0) | 37 | 0 | 14.78 ± 5.39 | |
Shokeir et al [19] | SWL | 6.4 ± 1.4 | 50 | 41 | NA(70) | NA(11) | NA(12) | 0(0) | 0(0) | 89 | 2 | 13.9 ± 4.2 |
PCNL | 6.6 ± 1.2 | 45 | 30 | NA(52) | NA(14) | NA(16) | 0(0) | 0(0) | 68 | 7 | 14.4 ± 3.1 | |
ElSheemy et al [20] | SWL | 4.06 ± 0.96 | 44 | 20 | 52 | 12 | 0(0) | 0(0) | 0(0) | 64 | 0 | 14.87 ± 4.05 |
PCNL | 3.84 ± 1.44 | 33 | 21 | 39 | 15 | 0(0) | 0(0) | 0(0) | 54 | 0 | 15.98 ± 4.31 | |
Mokhless et al [21] | SWL | 1~6 | 40 | 20 | 15(NA) | 5(NA) | 10(NA) | 0(0) | 0(0) | 60 | 0 | 10–20 |
RIRS | 2.4 ± 1.3 | 17(NA) | 7(NA) | 6(NA) | 0(0) | 0(0) | 10–20 | |||||
Freton et al [22] | SWL | 6.7 ± 0.6 | NA | Upper tract urinary stones (upper ureter or kidney) | NA | 19.5 ± 1.5 | ||||||
RIRS | 9.1 ± 0.9 | 21.6 ± 2.0 | ||||||||||
Resorlu et al [23] | PCNL | 9.6 ± 4.9 | 56 | 50 | 36(NA) | 70(NA) | 0(0) | 0(0) | 0(0) | 23.7 ± 4.42 | ||
RIRS | 9.3 ± 5.2 | 53 | 42 | 29(NA) | 66(NA) | 0(0) | 0(0) | 0(0) | 14.3 ± 3.81 | |||
Saad et al [24] | PCNL | 6.93 ± 3.55 | 14 | 8 | 2(2)b | 17(17)c | 3(3) | 22 | 0 | >20 | ||
RIRS | 6.44 ± 4.84 | 14 | 7 | 5(5)b | 11(11)c | 5(5) | 21 | 0 | >20 | |||
Bas et al [25] | PCNL | 5.62 ± 4.50 | 23 | 22 | 27 | 18 | 0(0) | 0(0) | 0(0) | 45 | 0 | 13.97 ± 3.46 |
RIRS | 8.39 ± 4.72 | 15 | 21 | 14 | 22 | 0(0) | 0(0) | 0(0) | 36 | 0 | 12.80 ± 3.03 | |
Sen et al [26] | PCNL | 4 ± 2.3 | NA | 1 | 24 | 0(0) | 0(0) | 0(0) | NA | 12.2 ± 2.8 | ||
RIRS | 10.9 ± 3 | 0 | 23 | 0(0) | 0(0) | 0(0) | 13.7 ± 3.5 | |||||
Pelit et al [27] | PCNL | 3.71 ± 1.89 | 24 | 21 | Renal stones | NA | 21.06 ± 5.61 | |||||
RIRS | 3.65 ± 1.95 | 17 | 15 | 19.30 ± 4.21 | ||||||||